🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 6 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 04/09/1996 | 0,1908 USD |
| 06/06/1996 | 0,1622 USD |
| 06/03/1996 | 0,1622 USD |
| 06/12/1995 | 0,1622 USD |
| 05/09/1995 | 0,1622 USD |
| 02/06/1995 | 0,1431 USD |
| 03/03/1995 | 0,1431 USD |
| 02/12/1994 | 0,1431 USD |
| 02/09/1994 | 0,1431 USD |
| 02/06/1994 | 0,1336 USD |
| 02/03/1994 | 0,1336 USD |
| 02/12/1993 | 0,1336 USD |
| 02/09/1993 | 0,1336 USD |
| 02/06/1993 | 0,1193 USD |
| 02/03/1993 | 0,1193 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 16/12/1999 | 68,23 | 68,23 | 65,48 | 66,26 | -3,14% | 4,02% | 5.145.051 |
| 15/12/1999 | 65,54 | 68,64 | 65,54 | 68,40 | +2,87% | 4,73% | 6.999.487 |
| 14/12/1999 | 64,89 | 66,50 | 63,75 | 66,50 | +2,11% | 4,23% | 7.688.442 |
| 13/12/1999 | 67,03 | 67,75 | 64,89 | 65,12 | -4,46% | 4,27% | 8.108.376 |
| 10/12/1999 | 68,40 | 69,36 | 67,63 | 68,17 | +0,35% | 2,53% | 5.540.986 |
| 09/12/1999 | 70,61 | 71,45 | 67,75 | 67,93 | -2,88% | 5,24% | 5.099.254 |
| 08/12/1999 | 70,85 | 70,91 | 69,06 | 69,94 | +0,15% | 2,61% | 5.423.400 |
| 07/12/1999 | 72,16 | 72,16 | 69,18 | 69,84 | -3,28% | 4,13% | 5.723.652 |
| 06/12/1999 | 74,19 | 74,19 | 71,62 | 72,21 | -2,20% | 3,46% | 4.663.286 |
| 03/12/1999 | 72,70 | 73,89 | 72,28 | 73,83 | +2,65% | 2,21% | 4.616.440 |
| 02/12/1999 | 71,09 | 72,64 | 71,09 | 71,92 | -1,33% | 2,18% | 3.638.761 |
| 01/12/1999 | 74,19 | 74,55 | 71,68 | 72,89 | -2,92% | 3,86% | 4.425.390 |
| 30/11/1999 | 75,92 | 76,10 | 74,37 | 75,08 | -1,64% | 2,28% | 4.273.010 |
| 29/11/1999 | 76,04 | 76,63 | 75,26 | 76,34 | +0,16% | 1,80% | 4.656.788 |
| 26/11/1999 | 76,28 | 76,34 | 75,98 | 76,22 | +0,24% | 0,47% | 2.155.002 |
| 24/11/1999 | 74,61 | 76,40 | 74,43 | 76,04 | +1,92% | 2,64% | 4.391.644 |
| 23/11/1999 | 75,20 | 75,26 | 73,89 | 74,61 | -0,69% | 1,82% | 2.606.166 |
| 22/11/1999 | 75,56 | 75,56 | 74,31 | 75,13 | -0,81% | 1,66% | 3.749.849 |
| 19/11/1999 | 74,49 | 76,04 | 74,49 | 75,74 | +0,87% | 2,08% | 4.341.550 |
| 18/11/1999 | 74,73 | 75,38 | 74,07 | 75,08 | +1,86% | 1,76% | 3.748.382 |
| 17/11/1999 | 72,46 | 74,43 | 72,28 | 73,71 | +1,64% | 2,96% | 5.182.150 |
| 16/11/1999 | 71,86 | 72,52 | 70,97 | 72,52 | +1,08% | 2,16% | 5.369.742 |
| 15/11/1999 | 71,80 | 72,64 | 71,56 | 71,74 | -0,99% | 1,50% | 3.922.350 |
| 12/11/1999 | 73,00 | 73,12 | 71,21 | 72,46 | -1,06% | 2,61% | 4.156.263 |
| 11/11/1999 | 73,83 | 74,01 | 71,86 | 73,23 | -1,05% | 2,91% | 4.127.234 |
| 10/11/1999 | 72,64 | 74,43 | 72,64 | 74,01 | -0,56% | 2,46% | 3.966.890 |
| 09/11/1999 | 75,56 | 75,74 | 74,13 | 74,43 | -1,19% | 2,13% | 2.846.473 |
| 08/11/1999 | 76,75 | 76,81 | 75,32 | 75,32 | -1,79% | 1,94% | 2.624.402 |
| 05/11/1999 | 76,28 | 77,41 | 75,86 | 76,69 | +0,86% | 2,03% | 3.999.378 |
| 04/11/1999 | 75,92 | 76,99 | 75,44 | 76,04 | +0,71% | 2,04% | 4.343.855 |